135 related articles for article (PubMed ID: 2246493)
1. Cimetidine 800 mg twice daily for healing erosions and ulcers in gastroesophageal reflux disease.
Palmer RH; Frank WO; Rockhold FW; Wetherington JD; Young MD
J Clin Gastroenterol; 1990; 12 Suppl 2():S29-34. PubMed ID: 2246493
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis.
Bate CM; Green JR; Axon AT; Murray FE; Tildesley G; Emmas CE; Taylor MD
Aliment Pharmacol Ther; 1997 Aug; 11(4):755-63. PubMed ID: 9305486
[TBL] [Abstract][Full Text] [Related]
3. Cimetidine QID and BID in rapid heartburn relief and healing of lesions in gastroesophageal reflux disease.
Palmer RH; Miller DM; Hedrich DA; Karlstadt RG
Clin Ther; 1993; 15(6):994-1001. PubMed ID: 8111819
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.
Richter JE; Peura D; Benjamin SB; Joelsson B; Whipple J
Arch Intern Med; 2000 Jun; 160(12):1810-6. PubMed ID: 10871975
[TBL] [Abstract][Full Text] [Related]
5. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis.
Bate CM; Green JR; Axon AT; Tildesley G; Murrays FE; Owen SM; Emmas C; Taylor MD
Aliment Pharmacol Ther; 1998 Jan; 12(1):41-7. PubMed ID: 9692699
[TBL] [Abstract][Full Text] [Related]
7. Ranitidine versus cimetidine in the healing of erosive esophagitis.
McCarty-Dawson D; Sue SO; Morrill B; Murdock RH
Clin Ther; 1996; 18(6):1150-60. PubMed ID: 9001831
[TBL] [Abstract][Full Text] [Related]
8. Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.
Cloud ML; Offen WW; Robinson M
Am J Gastroenterol; 1991 Dec; 86(12):1735-42. PubMed ID: 1962618
[TBL] [Abstract][Full Text] [Related]
9. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.
Behar J; Brand DL; Brown FC; Castell DO; Cohen S; Crossley RJ; Pope CE; Winans CS
Gastroenterology; 1978 Feb; 74(2 Pt 2):441-8. PubMed ID: 340333
[TBL] [Abstract][Full Text] [Related]
10. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Farley A; Wruble LD; Humphries TJ
Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
[TBL] [Abstract][Full Text] [Related]
11. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis.
Galmiche JP; Fraitag B; Filoche B; Evreux M; Vitaux J; Zeitoun P; Fournet J; Soule JC
Dig Dis Sci; 1990 May; 35(5):649-55. PubMed ID: 2331957
[TBL] [Abstract][Full Text] [Related]
12. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
Johnson DA; Benjamin SB; Vakil NB; Goldstein JL; Lamet M; Whipple J; Damico D; Hamelin B
Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
[TBL] [Abstract][Full Text] [Related]
14. On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo.
Galmiche JP; Shi G; Simon B; Casset-Semanza F; Slama A
Aliment Pharmacol Ther; 1998 Sep; 12(9):909-17. PubMed ID: 9768535
[TBL] [Abstract][Full Text] [Related]
15. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
16. Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment.
Miner PB; Johnson DA; Katz PO; Li J; Gatoulis SC; Pollack C
Adv Ther; 2018 Nov; 35(11):2024-2040. PubMed ID: 30255418
[TBL] [Abstract][Full Text] [Related]
17. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux.
Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF
Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725
[TBL] [Abstract][Full Text] [Related]
18. Cimetidine suspension in patients with stage 0 gastro-oesophageal reflux disease.
Riemann JF; Höbel W
Aliment Pharmacol Ther; 1991 Apr; 5(2):191-7. PubMed ID: 1888819
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial.
Karkon Varnosfaderani S; Hashem-Dabaghian F; Amin G; Bozorgi M; Heydarirad G; Nazem E; Nasiri Toosi M; Mosavat SH
J Integr Med; 2018 Mar; 16(2):126-131. PubMed ID: 29526236
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease.
Peura DA; Pilmer B; Hunt B; Mody R; Perez MC
Aliment Pharmacol Ther; 2013 Nov; 38(10):1303-11. PubMed ID: 24118079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
